Head-to-head · WeighScore
EOS Health vs Hims & Hers
By GLP-1 ScorecardUpdated
Score comparison
Hims & Hers has the higher recorded score — 75.6/100 to 62.8/100.
Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | EOS Health | Hims & Hers |
|---|---|---|
| WeighScore | 62.8/100 | 75.6/100 |
| Grade | C | C |
| Site position | #299 | #56 |
| Semaglutide | $199/mo (compounded) | $199/mo |
| Tirzepatide | $289/mo (compounded) | Not disclosed |
| Coverage | 40 states | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #299 · C
Strengths
- Unusually transparent: publicly names its clinical partner (Arora Health & Aesthetics, LLC) and pharmacy partner (F&F Pharmacies dba Jungle Jim's)
- Competitive compounded pricing from $199/mo semaglutide and $289/mo tirzepatide, plus $100 off the first prescription with code WELCOME100
- Multiple compounded formulas (semaglutide, semaglutide+glycine, semaglutide+B12, tirzepatide) and optional 130+ biomarker lab add-ons
- Free expedited shipping, no insurance required, 10-minute intake, and an ongoing care team via patient portal
What to consider
- Available in only 40 states — not offered in CA, NV, NJ, SC, TX, MA, MS, NH, WV, or DE (pharmacy partner is unlicensed there)
- Headline prices are 'best rate' figures; standard monthly plans may cost more than the quarterly-plan rate shown
- Compounded medication only — no brand-name or insurance-covered GLP-1 path
- Pharmacy partner's page notes it 'cannot dispense sterile compounds,' which is worth confirming for injectable GLP-1 fulfillment
Site position #56 · C
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Strengths
- Nationwide
- Polished app
- Strong brand trust
What to consider
- Tirzepatide pricing inconsistently disclosed
- Industry-wide compounding scrutiny
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.